|
Name |
Xenoacremone D
|
| Molecular Formula | C29H35NO5 | |
| IUPAC Name* |
3,22-dihydroxy-10,12-dimethyl-15-oxa-23-azaheptacyclo[12.9.3.216,19.11,22.04,9.010,26.025,28]triaconta-5,16(27),17,19(26)-tetraene-24,29-dione
|
|
| SMILES |
CC1CC(C)C2C(C1)C1C=CC3C(O)CC45CC(O)(Cc6ccc(cc6)OC2C1C3C4=O)NC5=O
|
|
| InChI |
InChI=1S/C29H35NO5/c1-14-9-15(2)22-20(10-14)18-7-8-19-21(31)12-28-13-29(34,30-27(28)33)11-16-3-5-17(6-4-16)35-25(22)23(18)24(19)26(28)32/h3-8,14-15,18-25,31,34H,9-13H2,1-2H3,(H,30,33)/t14-,15+,18+,19-,20+,21-,22-,23+,24+,25+,28+,29-/m1/s1
|
|
| InChIKey |
LRYAMUIPQBLDBG-QHHMGBMXSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 477.6 | ALogp: | 2.9 |
| HBD: | 3 | HBA: | 5 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 95.9 | Aromatic Rings: | 8 |
| Heavy Atoms: | 35 | QED Weighted: | 0.392 |
| Caco-2 Permeability: | -4.849 | MDCK Permeability: | 0.00028022 |
| Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.01 |
| Human Intestinal Absorption (HIA): | 0.145 | 20% Bioavailability (F20%): | 0.015 |
| 30% Bioavailability (F30%): | 0.005 |
| Blood-Brain-Barrier Penetration (BBB): | 0.389 | Plasma Protein Binding (PPB): | 96.18% |
| Volume Distribution (VD): | 2.227 | Fu: | 3.09% |
| CYP1A2-inhibitor: | 0.016 | CYP1A2-substrate: | 0.913 |
| CYP2C19-inhibitor: | 0.405 | CYP2C19-substrate: | 0.904 |
| CYP2C9-inhibitor: | 0.137 | CYP2C9-substrate: | 0.175 |
| CYP2D6-inhibitor: | 0.014 | CYP2D6-substrate: | 0.089 |
| CYP3A4-inhibitor: | 0.963 | CYP3A4-substrate: | 0.911 |
| Clearance (CL): | 16.654 | Half-life (T1/2): | 0.046 |
| hERG Blockers: | 0.028 | Human Hepatotoxicity (H-HT): | 0.212 |
| Drug-inuced Liver Injury (DILI): | 0.678 | AMES Toxicity: | 0.021 |
| Rat Oral Acute Toxicity: | 0.982 | Maximum Recommended Daily Dose: | 0.913 |
| Skin Sensitization: | 0.01 | Carcinogencity: | 0.104 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
| Respiratory Toxicity: | 0.854 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005770 | ![]() |
0.667 | D02FEM | ![]() |
0.225 | ||
| ENC005135 | ![]() |
0.636 | D0VA0I | ![]() |
0.224 | ||
| ENC005769 | ![]() |
0.598 | D03IKT | ![]() |
0.217 | ||
| ENC005768 | ![]() |
0.578 | D0W2EK | ![]() |
0.214 | ||
| ENC003851 | ![]() |
0.545 | D08PIQ | ![]() |
0.211 | ||
| ENC005767 | ![]() |
0.493 | D01XDL | ![]() |
0.209 | ||
| ENC005366 | ![]() |
0.489 | D0F1EX | ![]() |
0.208 | ||
| ENC003606 | ![]() |
0.489 | D0V9DZ | ![]() |
0.203 | ||
| ENC003349 | ![]() |
0.453 | D0I5DS | ![]() |
0.203 | ||
| ENC004852 | ![]() |
0.430 | D04SFH | ![]() |
0.201 | ||